Comparative analysis of genes regulated in acute myelomonocytic leukemia with and without inv(16)(p13q22) using microarray techniques, real-time PCR, immunohistochemistry, and flow cytometry immunophenotyping

Modern Pathology

Volumn 20, Issue 8, 2007, Pages 811-820

  Sun, Xiaoping ^a   Zhang, Wei ^a   Ramdas, Latha ^a   Stivers, David N ^a   Jones, Daniel M ^a   Kantarjian, Hagop M ^a   Estey, Elihu H ^a   Vadhan Raj, Saroj ^a   Medeiros, L Jeffrey ^a   Bueso Ramos, Carlos E ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

CBF MYH11; Gene expression; inv(16); Leukemia; M4Eo; NF B

Indexed keywords

ANTHRACYCLINE; CHIMERIC PROTEIN; COMPLEMENTARY DNA; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; FLUDARABINE; I KAPPA B; IDARUBICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TOPOTECAN;

ACUTE MYELOMONOCYTIC LEUKEMIA; ADULT; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; DRUG MECHANISM; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ADULT; AGED; APOPTOSIS; BONE MARROW; CELL PROLIFERATION; CHROMOSOMES, HUMAN, PAIR 16; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INVERSION, CHROMOSOME; LEUKEMIA, MYELOMONOCYTIC, ACUTE; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS, FUSION; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA;

EID: 34447579042     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800829     Document Type: Article

References (40)

1. Brunning RD, Matutes E, Flandrin G, et al. Acute myeloid leukaemia with recurrent genetic abnormalities. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds). World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of Haematopoietic and Lymphoid Tissues, IARC Press: Lyon, France, 2001, pp 82-84.
2. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British cooperative group. Ann Intern Med 1985;103:620-625.
3. Le Beau MM, Larson RA, Bitter MA, et al. Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association. N Engl J Med 1983;309:630-636.
4. Bitter MA, Le Beau MM, Larson RA, et al. A morphologic and cytochemical study of acute myelo-monocytic leukemia with abnormal marrow eosinophils associated with inv(16)(p13q22). Am J Clin Pathol 1984;81:733-741.
5. Bernard P, Dachary D, Reiffers J, et al. Acute nonlymphocytic leukemia with marrow eosinophilia and chromosome 16 abnormality: a report of 18 cases. Leukemia 1989;3:740-745.
6. Liu P, Tarle SA, Hajra A, et al. Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. Science 1993;261:1041-1044.
7. Liu PP, Wijmenga C, Hajra A, et al. Identification of the chimeric protein product of the CBFB-MYH11 fusion gene in inv(16) leukemia cells. Genes Chromosomes Cancer 1996;16:77-87.
8. Kanto S, Chiba N, Tanaka Y, et al. The PEBP2beta/CBF beta-SMMHC chimeric protein is localized both in the cell membrane and nuclear subfractions of leukemic cells carrying chromosomal inversion 16. Leukemia 2000;14:1253-1259.
9. Haferlach T, Winkemann M, Loffler H, et al. The abnormal eosinophils are part of the leukemic cell population in acute myelomonocytic leukemia with abnormal eosinophils (acute myeloid leukemia M4Eo) and carry the pericentric inversion 16: a combination of May-Grunwald-Giemsa staining and fluorescence in situ hybridization. Blood 1996; 87:2459-2463.
10. Marlton P, Keating M, Kantarjian H, et al. Cytogenetic and clinical correlates in acute myeloid leukemia patients with abnormalities of chromosome 16. Leukemia 1995;9:965-971.
11. Sun X, Medeiros LJ, Lu D, et al. Dysplasia and high proliferation rate are common in acute myeloid leukemia with inv(16)(p13q22). Am J Clin Pathol 2003;120:236-245.
12. Wong KF, Kwong YL. Trisomy 22 in acute myeloid leukemia: a marker for myeloid leukemia with monocytic features and cytogenetically cryptic inversion 16. Cancer Genet Cytogenet 1999;109:131-133.
13. Kundu M, Chen A, Anderson S, et al. Role of Cbfb in hematopoiesis and perturbations resulting from expression of the leukemogenic fusion gene Cbfb-MYH11. Blood 2002;100:2449-2456.
14. Shigesada K, van de Sluis B, Liu PP. Mechanism of leukemogenesis by the inv(16) chimeric gene CBFB/ PEBP2B-MHY11. Oncogene 2004;23:4297-4307.
15. Valk PJ, Verhaak RG, Beijen MA, et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 2004;350:1617-1628.
16. Bullinger L, Dohner K, Bair E, et al. Use of geneexpression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 2004;350:1605-1616.
17. Monica K, Galili N, Nourse J, et al. PBX2 and PBX3, new homeobox genes with extensive homology to the human proto-oncogene PBX1. Mol Cell Biol 1991;11:6149-6157.
18. Liu PP, Hajra A, Wijmenga C, et al. Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia. Blood 1995;85:2289-2302.
19. Zhao W, Claxton DF, Medeiros LJ, et al. Immunohistochemical analysis of CBFbeta-SMMHC protein reveals a unique nuclear localization in acute myeloid leukemia with inv(16)(p13q22). Am J Surg Pathol 2006;30:1436-1444.
20. Kirchner J, Bevan MJ. ITM2A is induced during thymocyte selection and T cell activation and causes downregulation of CD8 when overexpressed in CD4(+)CD8(+) double positive thymocytes. J Exp Med 1999;190:217-228.
21. Van den Plas D, Merregaert J. Constitutive overexpression of the integral membrane protein Itm2A enhances myogenic differentiation of C2C12 cells. Cell Biol Int 2004;28:199-207.
22. Van den Plas D, Merregaert J. In vitro studies on Itm2a reveal its involvement in early stages of the chondrogenic differentiation pathway. Biol Cell 2004;96: 463-470.
23. Senftleben U, Karin M. The IKK/NF-kappaB pathway. Crit Care Med 2002;30:S18-S26.
24. Wertz IE, O'Rourke KM, Zhou H, et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 2004;430:694-699.
25. Anderson DM, Maraskovsky E, Billingsley WL, et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 1997;390:175-179.
26. Galibert L, Tometsko ME, Anderson DM, et al. The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily. J Biol Chem 1998;273:34120-34127.
27. Bueso-Ramos CE, Rocha FC, Shishodia S, et al. Expression of constitutively active nuclear-kB RelA transcription factor in blasts of acute myeloid leukemia. Hum Pathol 2004;35:246-253.
28. Scorcioni F, Corti A, Davalli P, et al. Manipulation of the expression of regulatory genes of polyamine metabolism results in specific alterations of the cellcycle progression. Biochem J 2001;354:217-223.
29. Ignatenko NA, Babbar N, Mehta D, et al. Suppression of polyamine catabolism by activated Ki-ras in human colon cancer cells. Mol Carcinog 2004;39:91-102.
30. Wormald S, Hilton DJ. Inhibitors of cytokine signal transduction. J Biol Chem 2004;279:821-824.
31. Oyadomari S, Mori M. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ 2004;11:381-389.
32. Kilberg MS, Barbosa-Tessmann IP. Genomic sequences necessary for transcriptional activation by amino acid deprivation of mammalian cells. J Nutr 2002;132:1801-1804.
33. Shivakrupa R, Radha V, Sudhakar C, et al. Physical and functional interaction between Hck tyrosine kinase and guanine nucleotide exchange factor C3G results in apoptosis, which is independent of C3G catalytic domain. J Biol Chem 2003;278: 52188-52194.
34. Ravi R, Bedi A. NF-kappaB in cancer - a friend turned foe. Drug Resist Updat 2004;7:53-67.
35. Furukawa Y. Cell cycle control genes and hematopoietic cell differentiation. Leuk Lymphoma 2002;43: 225-231.
36. Radosevic N, Delmer A, Tang R, et al. Cell cycle regulatory protein expression in fresh acute myeloid leukemia cells and after drug exposure. Leukemia 2001;15:559-566.
37. Guttridge DC, Albanese C, Reuther JY, et al. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol 1999;19:5785-5799.
38. Bernardin-Fried F, Kummalue T, Leijen S, et al. Acute myeloid leukemia 1/RUNX1 increases during G1 to S cell cycle progression independent of cytokine-dependent phosphorylation and induces cyclin D3 gene expression. J Biol Chem 2004;279: 15678-15687.
39. Faderl S, Harris D, Van Q, et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces antiapoptotic and proapoptotic signals in acute myeloid leukemia. Blood 2003;102:630-637.
40. Care RS, Valk PJ, Goodeve AC, et al. Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias. Br J Haematol 2003;121:775-777.